SLDB
Solid Biosciences Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +10.0% ·
aandelenstroom +30.0% ·
netto nieuwe posities +9.1%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | +6 | 45.63M | $455.47M | +9 | −3 |
| Q1 2026 | 69 | 0 | 38.87M | $279.42M | +3 | −3 |
| Q4 2025 | 68 | +2 | 30.07M | $169.59M | +2 | — |
| Q3 2025 | 17 | +1 | 23.96M | $147.82M | +1 | — |
| Q2 2025 | 13 | -1 | 26.02M | $126.70M | +1 | −2 |
| Q1 2025 | 11 | +1 | 11.02M | $40.79M | +3 | −2 |
| Q4 2024 | 10 | -1 | 4.93M | $19.74M | +1 | −2 |
| Q3 2024 | 10 | +1 | 5.36M | $37.37M | +1 | — |
| Q2 2024 | 9 | — | 5.20M | $29.49M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 6.73M | +285.0% | $24.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.89M | +98.8% | $6.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.89M | +98.8% | $6.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 534.56K | -25.7% | $1.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 530.86K | +4.1% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 530.86K | +4.1% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 436.28K | +0.9% | $1.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 336.32K | +85.3% | $1.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 336.32K | +85.3% | $1.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 201.42K | Nieuw | $745,250 | 0.0% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 175.40K | +112.6% | $648,980 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 113.10K | Nieuw | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 113.10K | Nieuw | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 113.10K | Nieuw | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 113.10K | Nieuw | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 113.10K | Nieuw | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 69.49K | -49.0% | $257,128 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 11.56K | Nieuw | $43,000 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $745,250 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| T. Rowe Price | $43,000 | 0.0% |
Verlaten
| Wellington Management | $498,204 | was 0.0% |
| D. E. Shaw & Co. | $207,888 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 137 houders, 96.05M aandelen, $689.27M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.